APR 24, 2018 09:58 PM PDT

Improving Drug Discovery using Gold Nano-particles

WRITTEN BY: Nouran Amin

Investigators at University of Lincoln in the UK have developed a new technique using nanotechnology which may deliver drugs with high efficacy. This new technique has allowed scientists to ‘decorate’ gold nanoparticles using a protein of choice. This allows drugs to be tailored to target an area of the body for effective treatment, like a tumor growing on the pancreas.



Gold nanoparticles are tiny spheres made of gold atoms with a diameter of only a few billionths of a meter. They can be covered with a biological protein in combination with other drugs to enable the treatment to travel through the body and reach the affected area. These gold nanoparticles will 'adsorb' (hold on its surface) drugs which may otherwise be insoluble or quickly degradable in the blood, and due to their micro level size they can overcome multiple biological barriers like as skin, the small intestine and membranes which may inhibit the drug from reaching its target.

This unique technology is currently in use for real-world applications, but not common in drug development. For example, in pregnancy tests, gold nanoparticles coated with the antibody against the pregnancy hormone present in the urine will display the 'positive' strip if it reacts with the nanoparticles.

Until recently, ‘decorating’ nanoparticles with biological proteins used to be combined together with other particles which are not capable of controlling where they bind resulting in less drug effectiveness. But with this new method, pharmacologists are able to coat gold nanoparticles with proteins in a layer by layer and specific order organization. This maintains the protein to maximize drug efficacy, giving hope for a future in nanomedicine.


"Gold nanoparticles are a vital tool in new drug development and drug delivery systems. We have unlocked the key to binding proteins and molecules so that those drugs will be more effective,” explains Dr. Enrico Ferrari, a nanobiotechnologist from the University of Lincoln’s School of Life Science, "This method might help to design nanomedicines that do not need extensive chemical modification of a protein drug or a nano-carrier and therefore can be developed more easily and faster." Furthermore, investigators retrieved pieces of proteins isolated from bacteria and flatworms, and then fused those proteins together. It was found that the fusion was effective at binding to the gold nanoparticle surface and able to form stable bonds to any other protein.

Sources: Drug Discovery & Development
 

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 27, 2018
Drug Discovery
JUN 27, 2018
Potential Drug May 'Freeze' Cancer Cells
New research study is bringing hope to cancer patients undergoing the early stages of the disease, published in the journal Nature Communications, the stud...
JUL 13, 2018
Drug Discovery
JUL 13, 2018
Pharmacological Strategy Attempts To Treat Multiple Symptoms of Fragile X
Recent research in a mouse model of fragile X syndrome (FXS), scheduled for publication in Neuropsychopharmacology, shows that a pharmacological strategy c...
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
SEP 23, 2018
Cell & Molecular Biology
SEP 23, 2018
Insulin may be a new Colitis Treatment
Insulin is a necessary medicine for diabetics, but new work shows that insulin may also be used to treat chronic bowel inflammation....
SEP 30, 2018
Drug Discovery
SEP 30, 2018
Researchers Re-classify the 'Magic Mushroom' Drug
Researchers at John Hopkins have evaluated the safety and efficacy of compound, psilocybin, found in hallucinogenic mushrooms. They suggested that if evalu...
OCT 09, 2018
Drug Discovery
OCT 09, 2018
Weight Loss Drug Reduces Incidence of Diabetes
A clinical trial weight loss drug, by the name of Lorcaserin—manufactured by Eisai Inc., was found to reduce the risk of diabetes by 19 percent in pa...
Loading Comments...